Eli Lilly and Company (NYSE: LLY) is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar (Glucagon for Injection, 1 mg per vial; Diluent for ...

Eli Lilly issued a voluntary recall of a single lot of glucagon emergency kits used to treat severe hypoglycemia in diabetics after a patient reported a loss of drug potency and seizures.

Eli Lilly is recalling lot D239382D (glucagon for injection, 1 mg per vial; diluent for glucagon, 1 mL syringe), with the expiration date of April 2022. Source: Adobe Stock ...

Eli Lilly recalled an emergency kit that can save the lives of people with diabetes having severe hypoglycemia. The reason: “loss of potency” after the kit failed a customer who needed it.

(RTTNews) - Eli Lilly and Co. is recalling one lot of GLUCAGON Emergency Kit for low blood sugar to the consumer/user level citing loss of potency, the U.S. Food and Drug Administration announced.

Eli Lilly recalled an emergency kit that can save the lives of people with diabetes having severe hypoglycemia. The reason: “loss of potency” after the kit failed a customer who needed it.

Eli Lilly and Co. on Saturday recalled a single lot of its Glucagon Emergency Kit for Low Blood Sugar, following a patient complaint. The recall affects only lot D239382D, with an expiration date ...

Eli Lilly recalled an emergency kit that can save the lives of people with diabetes having severe hypoglycemia. The reason: “loss of potency” after the kit failed a customer who needed it.

A recently recalled batch of Glucagon Emergency Kits, Eli Lilly and Co’s therapy for diabetic patients in crisis, was manufactured at an Indiana factory cited by U.S. health regulators this year ...

--Eli Lilly and Company is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar, to the consumer/user level.